corbevax:   Biological E has delivered 100m Corbevax doses so far | India News – Times of India

corbevax: Biological E has delivered 100m Corbevax doses so far | India News – Times of India

HYDERABAD: Biological E (BE) Limited on Saturday announced that its Covid vaccine Corbevax has been approved by the Drug Controller General of India (DCGI) as a heterologous booster dose. “The booster dose of Corbevax increased the neutralising antibody (nAb) titers in the Covishield and Covaxin groups significantly when compared to placebo. In a subset of subjects evaluated for nAb against the Omicron variant, the Corbevax booster shot resulted in a significant increase in the nAb titers against the Omicron variant,” BE said.
“After the booster dose of Corbevax, Omicron nAbs were observed in 91% and 75% of subjects who had received primary vaccination by Covishield and Covaxin, respectively,” it added. Mahima Datla, managing director of Biological E, said that the approval will address the need for Cov id-19 booster doses in India. “We have crossed yet another milestone in our Covid-19 vaccination journey. This approval reflects once again the sustained world class safety standards and high immunogenicity of Corbevax. ”
Corbevax, which is an RBD protein subunit vaccine, had so far been approved for emergency use only in children. While EUA for the 12-14 years age group was granted in mid March, it got the nod for use in kids in the 5-11 years age in April. Till June 4, a little over 52 million doses of Corbevax were administered to children across the country, including over 17. 4 m illion who have completed the two-dose regimen. BE, which bagged an advance order from the Indian government for the supply of 300 million doses of Corbevax in June 2021, has so far delivered 100 million doses. In mid May, BE also slashed prices of the vaccine from Rs 840 per dose (with GST) to Rs 250 a dose, including GST, for private vaccination centres.

!(function(f, b, e, v, n, t, s) {
window.TimesApps = window.TimesApps || {};
const { TimesApps } = window;
TimesApps.loadFBEvents = function() {
(function(f, b, e, v, n, t, s) {
if (f.fbq) return;
n = f.fbq = function() {
n.callMethod ? n.callMethod(…arguments) : n.queue.push(arguments);
};
if (!f._fbq) f._fbq = n;
n.push = n;
n.loaded = !0;
n.version = ‘2.0’;
n.queue = [];
t = b.createElement(e);
t.async = !0;
t.src = v;
s = b.getElementsByTagName(e)[0];
s.parentNode.insertBefore(t, s);
})(f, b, e, v, n, t, s);
fbq(‘init’, ‘593671331875494’);
fbq(‘track’, ‘PageView’);
};
})(
window,
document,
‘script’,
‘https://connect.facebook.net/en_US/fbevents.js’,
);if(typeof window !== ‘undefined’) {
window.TimesApps = window.TimesApps || {};
const { TimesApps } = window;
TimesApps.loadScriptsOnceAdsReady = () => {
var scripts = [‘https://static.clmbtech.com/ad/commons/js/2658/toi/colombia_v2.js’,
‘https://www.googletagmanager.com/gtag/js?id=AW-877820074’,
‘https://imasdk.googleapis.com/js/sdkloader/ima3.js’,
‘https://tvid.in/sdk/loader.js’,
‘https://timesofindia.indiatimes.com/video_comscore_api/version-3.cms’,
‘https://timesofindia.indiatimes.com/grxpushnotification_js/minify-1,version-1.cms’,
‘https://connect.facebook.net/en_US/sdk.js#version=v10.0&xfbml=true’,
‘https://timesofindia.indiatimes.com/locateservice_js/minify-1,version-12.cms’
];
scripts.forEach(function(url) {
let script = document.createElement(‘script’);
script.type=”text/javascript”;
if(!false && !false && url.indexOf(‘colombia_v2’)!== -1){
script.src = url;
} else if (!false && !false && url.indexOf(‘sdkloader’)!== -1) {
script.src = url;
} else if (url.indexOf(‘colombia_v2’)== -1 && url.indexOf(‘sdkloader’)== -1){
script.src = url;
}
script.async = true;
document.body.appendChild(script);
});
}
}

Source link